Difficulty: Medium
Average Score: 92%
Practice
Which of the following antiparkinsonian drugs is an antiviral agent used in the prophylaxis of influenza A2?
Correct answer
D
Rationale
In the context of Safety Pharmacology Across the Lifespan, understanding the mechanisms of action of different drugs is essential for safe and effective pharmacological management. In this case, the correct answer is D) Amantadine.
Amantadine is an antiparkinsonian drug that also possesses antiviral properties, specifically against influenza A2. Its mechanism of action involves interfering with the viral replication process, making it effective in the prophylaxis of influenza A2 infections. This dual functionality of Amantadine makes it a unique therapeutic agent for both antiparkinsonian and antiviral purposes.
Regarding the other options:
A) Selegiline is a monoamine oxidase inhibitor used in the treatment of Parkinson's disease but does not possess antiviral properties.
B) Sinemet is a combination of levodopa and carbidopa used to manage symptoms of Parkinson's disease, not for antiviral prophylaxis.
C) Pergolide is a dopamine agonist primarily used in the treatment of Parkinson's disease and restless legs syndrome, without antiviral indications.
Understanding the specific indications and mechanisms of action of different drugs is crucial for healthcare professionals to make informed decisions in clinical practice. This knowledge ensures the safe and appropriate use of medications across various patient populations, emphasizing the importance of lifelong learning in pharmacology and patient care.
Amantadine is an antiparkinsonian drug that also possesses antiviral properties, specifically against influenza A2. Its mechanism of action involves interfering with the viral replication process, making it effective in the prophylaxis of influenza A2 infections. This dual functionality of Amantadine makes it a unique therapeutic agent for both antiparkinsonian and antiviral purposes.
Regarding the other options:
A) Selegiline is a monoamine oxidase inhibitor used in the treatment of Parkinson's disease but does not possess antiviral properties.
B) Sinemet is a combination of levodopa and carbidopa used to manage symptoms of Parkinson's disease, not for antiviral prophylaxis.
C) Pergolide is a dopamine agonist primarily used in the treatment of Parkinson's disease and restless legs syndrome, without antiviral indications.
Understanding the specific indications and mechanisms of action of different drugs is crucial for healthcare professionals to make informed decisions in clinical practice. This knowledge ensures the safe and appropriate use of medications across various patient populations, emphasizing the importance of lifelong learning in pharmacology and patient care.